-
No Claim Left Behind: Viability of Assessing Early Real-World Vaccine Effectiveness in Open and Closed Administrative Healthcare Claims
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of NALIRIFOX as First-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in Japan
Mar 10, 2025, 14:00 PM -
The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter
Mar 10, 2025, 14:00 PM -
Psychometric Validation and Meaningful Within-Patient Change of the FAACT-5IASS in Patients With Cancer Cachexia
Mar 10, 2025, 14:00 PM -
Exploring the Impact of Serum Phosphate Levels and Hyperphosphatemia on Renal Outcomes: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review
Mar 10, 2025, 14:00 PM -
Augmenting Small Training Datasets Improves Machine Learning Prognostic Performance
Mar 10, 2025, 14:00 PM -
Evaluating the Influence of User-Complexity on Individual Preferences for Upper Limb Prosthetic Selection: Measurement Tool Development for a Discrete Choice Experiment
Mar 10, 2025, 14:00 PM -
Is There Value in Knowing? Perspectives of Cancer Screening Outcomes Among the US General Population
Mar 10, 2025, 14:00 PM -
Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients
Mar 10, 2025, 14:00 PM -
Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Approaches to Model Patient And Carer Utilities and Disutilities of Adverse Events in Economic Models for Rare Disease Treatments in NICE Appraisals
Mar 10, 2025, 14:00 PM -
Do Existing Caregiver Assessments Measure What's Important to Caregivers?
Mar 10, 2025, 14:00 PM -
Comparing the Differences in MentalHealthcare Coverage Between US Public and Private Healthcare Insurers
Mar 10, 2025, 14:00 PM -
Systematic Literature Review on the Economic Burden of Myopia
Mar 10, 2025, 14:00 PM -
Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmentosa: 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)
Mar 10, 2025, 14:00 PM -
Ten-Year Trends in Potentially Inappropriate Sedative-Hypnotics and Pain Medication Use among Medicare Part D Beneficiaries
Mar 10, 2025, 14:00 PM -
Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States
Mar 10, 2025, 14:00 PM -
Three Different Methods to Estimate a Rare Disease (RD) Prevalence in a Country with a Limited Dataset: Which One Fits?
Mar 10, 2025, 14:00 PM -
Direct Costs of Pneumococcal Disease in the United States - A Targeted Literature Review
Mar 10, 2025, 14:00 PM
